Crescent Biopharma, Inc.CBIONASDAQ
LOADING
|||
Switch Symbol:
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -23.09% |
| Q2 2025 | -776.66% |
| Q1 2025 | 67.29% |
| Q4 2024 | 34.73% |
| Q3 2024 | -8.46% |
| Q2 2024 | 6.81% |
| Q1 2024 | -15.89% |
| Q4 2023 | 2.27% |
| Q3 2023 | -9.89% |
| Q2 2023 | 18.38% |
| Q1 2023 | -3.00% |
| Q4 2022 | -21.16% |
| Q3 2022 | 34.34% |
| Q2 2022 | 8.92% |
| Q1 2022 | 15.87% |
| Q4 2021 | -0.51% |
| Q3 2021 | -20.36% |
| Q2 2021 | -0.87% |
| Q1 2021 | 8.28% |
| Q4 2020 | -13.41% |
| Q3 2020 | 2.68% |
| Q2 2020 | -73.97% |
| Q1 2020 | 47.13% |
| Q4 2019 | -8.72% |
| Q3 2019 | 16.12% |
| Q2 2019 | -11.12% |
| Q1 2019 | -1.16% |
| Q4 2018 | -19.49% |
| Q3 2018 | -3.05% |
| Q2 2018 | -2.29% |
| Q1 2018 | -24.55% |
| Q4 2017 | -16.55% |
| Q3 2017 | 0.75% |
| Q2 2017 | -3.43% |
| Q1 2017 | 4.64% |
| Q4 2016 | -5.98% |
| Q3 2016 | 2.55% |
| Q2 2016 | -6.84% |
| Q1 2016 | 14.77% |
| Q4 2015 | -23.93% |